Health Care Equipment & Services

Medline insider buying signals confidence amid a volatile secondary offering, pointing to potential upside for investors eyeing healthcare supply stocks.

Orthofix Medical insider sales are routine tax‑cover moves, yet the firm’s strong clinical trials and FDA clearances suggest long‑term growth, reassuring investors and clinicians alike.

CEO sell‑to‑cover on Butterfly Network shares: routine tax move, minimal impact on stock, but highlights insider confidence and ongoing earnings challenges.

Andrea Frohning’s 5,957‑share sale at DENTSPLY SIRONA is routine tax‑covering activity, leaving long‑term investors a solid dental‑tech play amid steady gains and no major volatility.

GoodRx insider RSU buys signal long‑term confidence, but the company’s 50% YTD drop and low valuation demand cautious, data‑driven investment decisions.

Enovis insider buying signals confidence in its anti‑IL‑23 drug & diagnostic assays, despite negative earnings—potential game‑changer for psoriasis and rheumatoid arthritis care.

Beta Bionics insider sale shows disciplined, plan‑based trading amid phase‑III trials—insight into executive confidence and future upside potential.

Insider sales at Elevance Health reveal how a CMS suspension and rising regulatory pressures are reshaping Medicare Advantage, offering investors insight into volatility, strategy, and future upside.

Insider selling by Intuitive Surgical’s SVP shows routine, Rule 10b5‑1‑planned trades, while European distribution gains and strong clinical data keep investors confident in steady growth.

Teleflex CFO’s 400% jump in shares signals strong insider confidence in its growth strategy, hinting at a possible upside for investors.